Noradrenaline vs. terlipressin in the treatment of hepatorenal syndrome: a randomized study V Singh, S Ghosh, B Singh, P Kumar, N Sharma, A Bhalla, AK Sharma, ... Journal of hepatology 56 (6), 1293-1298, 2012 | 325 | 2012 |
Noradrenaline vs terlipressin in the treatment of type 2 hepatorenal syndrome: a randomized pilot study S Ghosh, NS Choudhary, AK Sharma, B Singh, P Kumar, R Agarwal, ... Liver International 33 (8), 1187-1193, 2013 | 133 | 2013 |
Radiolabeling optimization and characterization of 68Ga labeled DOTA–polyamido-amine dendrimer conjugate–animal biodistribution and PET imaging results A Ghai, B Singh, PP Hazari, MK Schultz, A Parmar, P Kumar, S Sharma, ... Applied radiation and isotopes 105, 40-46, 2015 | 49 | 2015 |
Recent developments of target based coumarin derivatives as potential anticancer agents NS Goud, P Kumar, RD Bharath Mini reviews in medicinal chemistry 20 (17), 1754-1766, 2020 | 43 | 2020 |
Fluorine-18: A radionuclide with diverse range of radiochemistry and synthesis strategies for target based PET diagnosis NS Goud, RK Joshi, RD Bharath, P Kumar European Journal of Medicinal Chemistry 187, 111979, 2020 | 39 | 2020 |
Carbon-11: radiochemistry and target-based PET molecular imaging applications in oncology, cardiology, and neurology NS Goud, A Bhattacharya, RK Joshi, C Nagaraj, RD Bharath, P Kumar Journal of Medicinal Chemistry 64 (3), 1223-1259, 2021 | 35 | 2021 |
Murine MPDZ‐linked hydrocephalus is caused by hyperpermeability of the choroid plexus J Yang, C Simonneau, R Kilker, L Oakley, MD Byrne, Z Nichtova, ... EMBO Molecular Medicine 11 (1), e9540, 2019 | 29 | 2019 |
VPAC1 targeted 64Cu-TP3805 positron emission tomography imaging of prostate cancer: Preliminary evaluation in man S Tripathi, EJ Trabulsi, L Gomella, S Kim, P McCue, C Intenzo, R Birbe, ... Urology 88, 111-118, 2016 | 29 | 2016 |
Preclinical evaluation of [99m] Tc-labeled doxorubicin as a potential scintigraphic probe for tumor imaging P Kumar, B Singh, S Sharma, A Ghai, K Chuttani, AK Mishra, D Dhawan, ... Cancer Biotherapy and Radiopharmaceuticals 27 (3), 221-225, 2012 | 23 | 2012 |
Synthesis, 18F-radiolabeling and apoptosis inducing studies of novel 4, 7-disubstituted coumarins NS Goud, VKK Makani, J Pranay, R Alvala, IA Qureshi, P Kumar, ... Bioorganic Chemistry 97, 103663, 2020 | 19 | 2020 |
Development of a single vial kit formulation of [99mTc]‐labeled doxorubicin for tumor imaging and treatment response assessment‐preclinical evaluation and preliminary human results P Kumar, B Singh, A Ghai, PP Hazari, BR Mittal, AK Mishra Journal of Labelled Compounds and Radiopharmaceuticals 58 (6), 242-249, 2015 | 18 | 2015 |
Evaluating Ga-68 peptide conjugates for targeting VPAC receptors: stability and pharmacokinetics P Kumar, SK Tripathi, CP Chen, E Wickstrom, ML Thakur Molecular Imaging and Biology 21, 130-139, 2019 | 13 | 2019 |
Radiosynthesis challenges of 11C and 18F-labeled radiotracers in the FX2C/N tracerlab and their validation through PET-MR imaging RK Joshi, NS Goud, C Nagaraj, D Kumar, R Gopinath, NP Rao, ... Applied Radiation and Isotopes 168, 109486, 2021 | 12 | 2021 |
Evaluation of a PACAP Peptide Analogue Labeled with 68Ga Using Two Different Chelating Agents P Kumar, SK Tripathi, CP Chen, N Mehta, B Paudyal, E Wickstrom, ... Cancer Biotherapy and Radiopharmaceuticals 31 (1), 29-36, 2016 | 9 | 2016 |
Role of neuroimaging in drug development B Medhi, S Misra, PK Avti, P Kumar, H Kumar, B Singh Reviews in the Neurosciences 25 (5), 663-673, 2014 | 8 | 2014 |
Radiosynthesis of [18F] flumazenil for imaging benzodiazepine receptors and its evaluation in human volunteers using simultaneous PET-MRI P Kumar, C Nagaraj, R Joshi, NS Goud, D Kumar, V Korann, S Mangalore, ... Journal of Radioanalytical and Nuclear Chemistry 329 (2), 581-589, 2021 | 7 | 2021 |
VPAC1 Targeted 64Cu-TP3805 kit preparation and its evaluation SK Tripathi, P Kumar, EJ Trabulsi, S Kim, PA McCue, C Intenzo, A Berger, ... Nuclear medicine and biology 51, 55-61, 2017 | 6 | 2017 |
Automated radiosynthesis and molecular docking studies of coumarin-triazole hybrid with fluorine-18: a feasibility study NS Goud, MS Ghouse, C Nagaraju, RD Bharath, M Alvala, P Kumar Current Radiopharmaceuticals 15 (1), 40-49, 2022 | 5 | 2022 |
Preclinical evaluation of 99mTc labeled gefitinib as a potential scintigraphic probe for the detection of tumors expressing epidermal growth factor receptors P Kumar, B Singh, A Ghai, K Chuttani, D Dhawan, BR Mittal, AK Mishra Applied Radiation and Isotopes 99, 41-45, 2015 | 4 | 2015 |
Can High b Value Diffusion Be a Surrogate Marker for PET—A MR/PET Study in Neurooncology Set Up S Mangalore, S Vankayalapati, S Jabeen, A Kumar Gupta, P Kumar Frontiers in Neurology 12, 627247, 2021 | 2 | 2021 |